The vulnerability of breast cancer cells to ferroptosis is influenced by subtype-specific signaling pathways as well as a meticulously regulated network focused on essential genes such as p53, Breast Cancer vulnerability Gene 1 (BRCA1) and the PI3K–protein kinase B (AKT) pathway. This evidence concerns the gene TP53 and breast carcinoma.